Finally, they observed that CAT overexpression protects cancer cells against the pro-oxidant combination of ascorbate and menadione, suggesting that changes in the expression of antioxidant enzymes could be a mechanism of resistance of cancer cells toward redox-based chemotherapeutic drugs [97]. This evidence concerns the gene CAT and cancer.